Only 37% of orphan medicines are reimbursed in Ireland. Rare Diseases Ireland calling for faster access.
Rare Diseases Ireland has highlighted a critical issue: 163 orphan medicines now have EU approval, but people living with rare diseases in Ireland face long delays getting access. They're urging the Minister for Health to establish an Early Access Scheme so patients can get life-changing treatments within one year of approval, not years down the line.
Click to englarge